This website isn’t supported by Internet Explorer. We recommend that you use a different browser (e.g. Edge, Chrome, Firefox, Safari, or similar) for the best experience of our content.
Science Hub

Welcome to Novo Nordisk Science Hub

The information on this website is intended for healthcare professionals only and is provided solely for the purpose of scientific exchange. By accessing this website you accept this legal disclaimer and you expressly confirm your status as a healthcare professional.


This website is not country specific and may therefore contain information that is not applicable to your country. The website is not intended to provide medical advice and/or treatment guidance. Therefore, before prescribing any product, always refer to information approved by regulatory authorities in your country such as the prescribing information and/or the Summary of Product Characteristics. Novo Nordisk accepts no liability for the accuracy, completeness or use of information on this website, and disclaims any liability to update the information contained on this website.

Are you a healthcare professional?

Speaker - Charis Segeritz-Walko
PhD, Novo Nordisk A/S, Denmark

Charis Segeritz-Walko is Director of Innovation Projects in Novo Nordisk’s Cell Therapy R&D department. In this role, she oversees the exploration and evaluation of new project ideas and partnerships, and their maturation into Novo Nordisk’s early project portfolio. She previously contributed as a Principal Scientist to Novo Nordisk’s department for Global Drug Development by establishing advanced human in vitro models for drug target discovery and validation. Prior to joining Novo Nordisk, Charis lead a R&D team at STEMCELL Technologies, advancing products for stem cell differentiation from ideation to market launch. Charis holds a Ph.D. in stem cell biology and regenerative medicine from the University of Cambridge.